Publication|Articles|September 19, 2025
- Pharmaceutical Executive: September 2025
- Volume 45
- Issue 7
Pharmaceutical Executive: September 2025 Interactive Digital Edition
View the Pharmaceutical Executive September 2025 issue in an interactive format.
Advertisement
Click
Articles in this issue
3 months ago
Can AI Point the Way?3 months ago
Turning AI Pilots into Enterprise Value3 months ago
Paul Hudson: A Mindset for Miracles3 months ago
How AI is Shaping KOL and DOL Identification3 months ago
Measuring the ROI of SPP Adherence ProgramsNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Sanofi Reaches Deals with ADEL for Novel Alzheimer’s Disease Drug, Dren Bio for B-cell Depletion Therapy
2
FDA Approves Enhertu Plus Perjeta as First-Line Therapy for HER2-Positive Metastatic Breast Cancer
3
Lunit and Daiichi Sankyo Form Collaboration to Advance Research and Discovery for AI-Driven Biomarkers and Translational Oncology
4
Pharmaceutical Executive Daily: TrumpRx's Critical Blind Spot
5

